SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318154-19-000046
Filing Date
2019-10-30
Accepted
2019-10-29 19:31:34
Documents
85
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q amgn-2019930x10q.htm   iXBRL 10-Q 3089138
2 RULE 13A-14(A) CERTIFICATIONS amgn-ex312019930xq3.htm EX-31 23787
3 SECTION 1350 CERTIFICATIONS amgn-ex322019930xq3.htm EX-32 10910
  Complete submission text file 0000318154-19-000046.txt   12804007

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amgn-20190930.xsd EX-101.SCH 57492
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amgn-20190930_cal.xml EX-101.CAL 88566
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amgn-20190930_def.xml EX-101.DEF 320281
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amgn-20190930_lab.xml EX-101.LAB 740985
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amgn-20190930_pre.xml EX-101.PRE 458610
21 EXTRACTED XBRL INSTANCE DOCUMENT amgn-2019930x10q_htm.xml XML 3224779
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37702 | Film No.: 191176761
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences